LionBird

LionBird is an early-stage venture capital firm with offices in Tel Aviv, Israel, and New York, USA. The firm primarily focuses on investing in seed and pre-seed stage technology startups, with a specific emphasis on digital health and enterprise SaaS solutions. Their investment thesis revolves around identifying companies that leverage technology to improve and optimize traditionally offline processes, bringing efficiency and innovation to established sectors.

As active and hands-on investors, LionBird partners closely with founders, leveraging their deep operational experience to help portfolio companies scale and achieve market leadership. They are known for their collaborative approach, providing strategic guidance and access to networks beyond just capital. LionBird typically deploys initial investments ranging from $1 million to $3 million, targeting companies that demonstrate strong potential for disruption and significant market impact.

LionBird has demonstrated consistent growth in its funding capabilities, successfully raising substantial capital to support its investment activities. In 2019, the firm closed its third fund, LionBird III, with $75 million in commitments. Building on this momentum, they further expanded their capacity by raising LionBird IV, a $100 million fund, which closed in April 2022. To date, LionBird has built a robust portfolio of over 50 companies, reflecting their commitment to fostering innovation across their target sectors. Their dual presence in key tech hubs like Tel Aviv and New York allows them to tap into diverse talent pools and market opportunities.